| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.0M | -56.4% | +0.5% |
| Cost of Revenue | $1.1M | -71.7% | -26.9% |
| Gross Profit | $928K | +20.1% | +80.3% |
| R&D Expense | $404K | +586.9% | +1345.2% |
| SG&A Expense | $3.0M | -40.6% | +62.6% |
| Operating Income | -$2.6M | +41.3% | -91.5% |
| Net Income | -$3.0M | +45.3% | -109.0% |
| EPS (Basic) | -$0.08 | +50.0% | -100.0% |
| EPS (Diluted) | -$0.08 | +50.0% | -100.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $11.5M | +4635.7% | +2042.1% |
| Accounts Receivable | $6.1M | +15.5% | +160.2% |
| Inventory | $2.2M | +18.2% | -3.8% |
| Current Assets | $22.2M | +185.6% | +289.2% |
| Total Assets | $25.7M | +153.8% | +349.3% |
| Current Liabilities | $2.7M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$8.2M | — | — |
| Investing Cash Flow | -$2.8M | — | — |
| Financing Cash Flow | $21.6M | — | — |
| +82.8% |
| Total Liabilities | $3.5M | -31.8% | +84.8% |
| Stockholders' Equity | $22.2M | +343.4% | +479.7% |